Q2 2020 Holdings
Filed 2020-07-20 | 12 holdings | $696.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Crispr Therapeutics AG(CRSP) | Common Stock | H17182108 | $307.4M | 4,183,064 | 44.2% |
| Adverum Biotechnologies, Inc.(ADVMCHF) | Common Stock | 00773U108 | $146.2M | 7,003,892 | 21.0% |
| Aprea Therapeutics, Inc. | Common Stock | 03836J102 | $71.9M | 1,854,229 | 10.3% |
| Akero Therapeutics, Inc.(AKRO) | Common Stock | 00973Y108 | $52.7M | 2,115,454 | 7.6% |
| Crinetics Pharmaceuticals, Inc.(CRNX) | Common Stock | 22663K107 | $35.6M | 2,030,616 | 5.1% |
| Veracyte, Inc.(VCYT) | Common Stock | 92337F107 | $31.2M | 1,205,407 | 4.5% |
| Gritstone Oncology, Inc.(2JQ) | Common Stock | 39868T105 | $20.6M | 3,102,929 | 3.0% |
| Ocular Therapeutix, Inc.(OCUL) | Common Stock | 67576A100 | $18.5M | 2,215,384 | 2.7% |
| Iveric bio, Inc.(OPHTEUR) | Common Stock | 46583P102 | $8.8M | 1,724,909 | 1.3% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | Common Stock | 23257D103 | $1.9M | 543,753 | 0.3% |
| Clovis Oncology, Inc.(CLVSEUR) | Common Stock | 189464100 | $687.5K | 101,855 | 0.1% |
| Second Sight Medical Products, Inc. | Common Stock | 81362J100 | $550.2K | 561,612 | 0.1% |